TSE:247A
TSE:247AMedia

Top Asian Growth Companies With High Insider Ownership December 2025

As we approach the end of 2025, Asian markets are navigating a complex landscape marked by global economic shifts and monetary policy adjustments. With central banks like the Federal Reserve lowering interest rates in response to labor market concerns, investors are increasingly focused on growth companies that demonstrate resilience and potential for long-term value creation. In this context, stocks with high insider ownership can be particularly attractive as they often indicate strong...
SEHK:2306
SEHK:2306Entertainment

Asian Penny Stocks To Watch In December 2025

As global markets react to recent economic developments, such as interest rate cuts by the Federal Reserve and concerns over technology stock valuations, investors are keeping a close eye on Asia's financial landscape. In this context, penny stocks—though an outdated term—remain relevant as they often represent smaller or newer companies with potential for growth. By focusing on those with strong financial health and clear growth trajectories, investors can uncover opportunities among these...
TPEX:3152
TPEX:3152Communications

Exploring Undiscovered Gems in Asia December 2025

As global markets navigate a landscape of interest rate adjustments and economic uncertainties, the Asian market presents unique opportunities, particularly in the small-cap sector. With recent shifts in monetary policy and evolving economic indicators, identifying stocks with strong fundamentals and growth potential becomes crucial for investors seeking to uncover undiscovered gems.
SZSE:002555
SZSE:002555Entertainment

3 Asian Dividend Stocks Yielding Up To 6.7%

As global markets navigate a complex landscape marked by interest rate adjustments and economic uncertainties, investors are increasingly turning their attention to Asia for opportunities. In this context, dividend stocks in the region stand out as attractive options for those seeking income stability amid fluctuating market conditions.
NYSE:BFLY
NYSE:BFLYMedical Equipment

Butterfly Network (BFLY): Valuation Check After Midjourney Deal, Insider Buying and Compass AI Launch

Butterfly Network (BFLY) is back on traders radar after a three way catalyst: a fresh licensing and co development deal with Midjourney, a director share purchase, and the launch of its Compass AI platform. See our latest analysis for Butterfly Network. Those catalysts have arrived against a backdrop of a sharp turnaround in sentiment. Butterfly’s 30 day share price return of 60.9 percent and 90 day gain of 67.7 percent contrast with a still modest 1 year total shareholder return of 1.6...
NasdaqGM:RILY
NasdaqGM:RILYCapital Markets

B. Riley Financial (RILY): Evaluating Valuation After a Sharp Earnings Rebound and Profitability Turnaround

B. Riley Financial (RILY) just swung from a huge loss to solid profitability in its latest second quarter report, with revenue more than doubling and earnings per share flipping sharply back into positive territory. See our latest analysis for B. Riley Financial. The strong earnings rebound comes after a volatile stretch, with a sharp 1 day share price return of minus 17.5 percent and a 90 day share price return of minus 34.1 percent. The 3 year total shareholder return of minus 84.4 percent...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

DiDi (OTCPK:DIDI.Y): Valuation Check After Robotaxi Trials, Self‑Driving Fundraise, Buyback and IPO Settlement Progress

DiDi Global (OTCPK:DIDI.Y) is back in focus after launching 24/7 fully unmanned robotaxi trials in Guangzhou, raising fresh capital for its self-driving arm, completing a major buyback, and nearing closure on a sizeable U.S. IPO lawsuit settlement. See our latest analysis for DiDi Global. Despite the legal overhang easing and the robotaxi push signalling long term growth ambitions, DiDi Global’s 30 day share price return of 3.18 percent contrasts with a still weak 90 day share price return of...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix (CRMD): Reassessing Valuation After Strong Multi‑Year Share Price Performance

CorMedix (CRMD) has quietly delivered a strong year so far, and investors are starting to ask whether the recent share performance lines up with the company’s growth profile and risk-reward trade off. See our latest analysis for CorMedix. With the share price now at $11.45, CorMedix has seen a punchy year to date, with a 39.29% year to date share price return and a standout 3 year total shareholder return of 189.87%. This suggests momentum has been building as investors reassess its growth...
NYSE:CI
NYSE:CIHealthcare

What Cigna Group (CI)'s Rising Medical Costs And Securities Probe Mean For Shareholders

Recently, BofA Securities highlighted The Cigna Group’s exposure to commercial health insurance and its scaled pharmaceutical platform, while Levi & Korsinsky began investigating potential federal securities law violations following Cigna’s disclosure of a higher Healthcare medical cost ratio that could pressure future profitability. This combination of optimism around pharmacy-driven earnings growth and scrutiny of rising medical costs underscores the tension between Cigna’s long-term...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos (LDOS): Valuation Check After Hiring AI Veteran Ted Tanner Jr. as Chief Technology Officer

Leidos Holdings (LDOS) just made a strategically interesting move, naming AI veteran Theodore Ted Tanner Jr. as its next chief technology officer. Investors are already asking what this could mean for the stock. See our latest analysis for Leidos Holdings. That AI focused CTO hire lands at an interesting moment, because while the 1 month share price return is slightly negative, the year to date share price return of 26.6 percent and a three year total shareholder return near 79.5 percent show...